Is 500 mg of gentamicin (intravenous) appropriate for treating brucellosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gentamicin Dosing for Brucellosis Treatment

For brucellosis treatment, 500 mg of gentamicin IV is not the recommended dose; instead, gentamicin should be dosed at 5 mg/kg daily parenterally in a single dose for 7 days, combined with doxycycline 100 mg twice daily orally for 6 weeks. 1, 2

Recommended Treatment Regimens for Brucellosis

First-Line Options:

  • Doxycycline-Streptomycin: Doxycycline 100 mg twice daily orally for 6 weeks plus streptomycin 15 mg/kg daily intramuscularly for 2-3 weeks (AI recommendation) 1
  • Doxycycline-Rifampicin: Doxycycline 100 mg twice daily orally for 6 weeks plus rifampicin 600-900 mg daily as a single morning dose for 6 weeks (AI recommendation) 1

Preferred Alternative Regimen:

  • Doxycycline-Gentamicin: Doxycycline 100 mg twice daily orally for 6 weeks plus gentamicin 5 mg/kg daily parenterally in a single dose for 7 days (BI recommendation) 1, 2
    • This combination offers advantages over doxycycline-streptomycin due to wider availability of gentamicin and sparing streptomycin for tuberculosis treatment 1, 2
    • Studies have shown relapse rates comparable to WHO-recommended regimens 1, 3

Gentamicin Dosing Considerations

  • The fixed dose of 500 mg gentamicin is not recommended in guidelines; weight-based dosing at 5 mg/kg daily is the standard 1, 2
  • Duration should be 7 days when combined with doxycycline 1, 2
  • Some studies suggest gentamicin duration could be shortened to 5 days or extended to 14 days for optimal results 1
  • A recent study demonstrated that gentamicin at 5 mg/kg/day for one week is safe with minimal risk of nephrotoxicity in brucellosis patients 4

Treatment Efficacy Data

  • Non-comparative studies using gentamicin for 5-7 days showed failure/relapse rates of 10-20%, which is approximately 5% higher than WHO-recommended regimens 1
  • A randomized trial comparing gentamicin (5 mg/kg daily for 5 days) plus doxycycline (8 weeks) versus streptomycin (2 weeks) plus doxycycline (45 days) showed similar efficacy (95.12% vs 89%) 5
  • Another study showed that doxycycline for 45 days plus gentamicin for 7 days had a lower relapse rate (5.9%) compared to doxycycline for 30 days plus gentamicin for 7 days (22.9%) 3

Important Clinical Considerations

  • The combination of doxycycline and gentamicin is considered an adequate regimen with advantages over doxycycline-streptomycin 1, 2
  • Gentamicin is effective against Brucella melitensis and can be used when the classical combination is considered first choice 6
  • Monitor renal function when using gentamicin, although recent evidence suggests minimal nephrotoxicity risk at recommended doses 4
  • In regions where brucellosis and tuberculosis coexist, gentamicin may be preferred over rifampicin to avoid contributing to mycobacterial resistance 2, 7

Treatment Duration

  • Standard treatment duration is 6 weeks for doxycycline when combined with gentamicin for 7 days 1, 2
  • Shortening doxycycline treatment to 30 days results in higher relapse rates (22.9%) compared to 45 days (5.9%) 3
  • Relapse rates range from 5-15% even with appropriate treatment 2, 7

Remember that the appropriate treatment of brucellosis requires combination therapy, and fixed-dose gentamicin at 500 mg is not recommended by current guidelines. Weight-based dosing at 5 mg/kg daily for 7 days in combination with doxycycline for 6 weeks is the recommended approach.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Brucellosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of human brucellosis with doxycycline and gentamicin.

Antimicrobial agents and chemotherapy, 1997

Guideline

Brucellosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.